Site-Specific Traceless Coupling of Potent Cytotoxic Drugs to Recombinant Antibodies for Pharmacodelivery
- 6 March 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 134 (13) , 5887-5892
Abstract
Aldehyde drugs are gaining increasing research interest, considering that aldehyde dehydrogenases overexpression is characteristic of cancer stem cells. Here, we describe the traceless site-specific coupling of a novel potent drug, containing an aldehyde moiety, to recombinant antibodies, which were engineered to display a cysteine residue at their N-terminus, or a 1,2-aminothiol at their C-terminus. The resulting chemically defined antibody-drug conjugates represent the first example in which a thiazolidine linkage is used for the targeted delivery and release of cytotoxic agents.Keywords
This publication has 41 references indexed in Scilit:
- Choosing an effective protein bioconjugation strategyNature Chemical Biology, 2011
- The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasisClinical & Experimental Metastasis, 2011
- Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of MetastasisStem Cells, 2010
- Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritisArthritis Research & Therapy, 2009
- High-efficiency labeling of sialylated glycoproteins on living cellsNature Methods, 2009
- The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and MetastasesCancer Research, 2007
- Scalable transient gene expression in Chinese hamster ovary cells in instrumented and non-instrumented cultivation systemsBiotechnology Letters, 2007
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Direct Production of Proteins with N-Terminal Cysteine for Site-Specific ConjugationBioconjugate Chemistry, 2004
- Efficient one-step direct labelling of recombinant antibodies with technetium-99mEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995